| Literature DB >> 30814071 |
Helong Wang1, Jing He1, Yulan Luo1, MiMi Mu1, Shujun Guo1, Lin Shen2, Zhongqing Qian1, Qiang Fang3, Chuanwang Song4.
Abstract
Airway inflammation can be mitigated when apoptotic cells are engulfed by pulmonary epithelial cells. Insulin-like growth factor 1 (IGF-1), a single chain polypeptide growth factor, is the main mediator of growth hormone activity in vivo. IGF-1 has many biological activities, such as the regulation of cell survival, proliferation, differentiation and metabolism. However, its effect on the engulfment of cells, especially by non-professional phagocytes such as alveolar epithelial cells (AECs), has not been fully elucidated. We report that IGF-1 increases endocytosis in a mouse alveolar epithelial cell line, MLE-12. The PI3K-Akt pathway is involved in this effect of IGF-1. Furthermore, IGF-1 can inhibit the production of interleukin-6 in lipopolysaccharide-stimulated AECs. We have found that IGF-1 can enhance endocytosis of AECs through the PI3K pathway and exhibit anti-inflammatory properties. These two observations suggest that IGF-1 is a potential mediator in the regulation of airway inflammation.Entities:
Keywords: IGF-1; PI3K-Akt pathway; alveolar epithelial cells; endocytosis
Mesh:
Substances:
Year: 2019 PMID: 30814071
Source DB: PubMed Journal: Ann Clin Lab Sci ISSN: 0091-7370 Impact factor: 1.256